Augmenting factors for human antibody production and process for peparing the same

Claim 2

Augmenting and enhancing factor for human antibody production wherein the factor is obtained from the supernatant of cultured human lymphocytes and the factor has physicochemical and biological properties as follows: (a) molecular weight of 2,000-4,000; (b) passage through a cellulose dialysis membrane having a diameter of 6 mm, a thickness of 0.0508 mm and a porosity diameter of 24A; (c) stability at pH 2-11; (d) (i) stability on heating at 30° C. for 60 minutes, at 56° C. for 30 minutes and at 100° C. for 2 minutes, (ii) stability to six repetitions of freeze-thawing with freezing at -80° C. and thawing at 37° C.; (e) (i) inactivation on treatment with proteinase K at 37° C. for 60 minutes, (ii) stability to a treatment with ribonuclease A at 37° C. for 60 minutes; and (f) (i) augmentation and enhancement of the production of immunoglobulins, IgG and IgM by human lymphocytes; (ii) exhibition of no activity of T-cell growth factor (TCGF); (iii) exhibition of no activity of B-cell growth factor (BCGF), and (iv) exhibition of no activity of B-cell differentiation factor (BCDF).

Claim 3

Augmenting and enhancing factors in accordance with claim 1, wherein the human lymphocytes are mononuclear cells obtained from tonsils, spleens, thymus or peripheral blood.

Claim 4

A process for preparing augmenting and enhancing factors for human antibody production from cultured human lymphocytes comprising: separating nylon wool-adherent human lymphocytes from nylon wool-passed human lymphocytes, culturing the nylon wool-adherent human lymphocytes, dialyzing the culture medium, and obtaining diffused dialysate through a dialysis membrane, said dialysate containing the augmenting and enhancing factors which factors have a molecular weight of about 2,000-4,000.

Claim 5

A process for preparing augmenting and enhancing factors for human antibody production from cultured human lymphocytes comprising: separating nylon wool-adherent human lymphocytes from nylon wool-passed human lymphocytes, culturing the nylon wool-adherent human lymphocytes, dialyzing the culture medium, and obtaining diffused dialysate through a dialysis membrane, said dialysate containing the augmenting and enhancing factors which factors have a molecular weight of about 2,000-4,000.

Claim 6

A process for preparing augmenting and enhancing factors in accordance with claim 3, wherein the human lymphocytes are mononuclear cells obtained from tonsils, spleens, thymus or peripheral blood of humans.

Claim 7

A process for preparing augmenting and enhancing factors in accordance with claim 3, wherein the nylon wool-adherent cells are cultured in a culture medium supplemented with fetal calf serum in an atmosphere of carbon dioxide and at a temperature of about 35°-38° C.

Claim 8

A process for preparing augmenting and enhancing factors in accordance with claim 3, further comprising lyophilizing the dialysate.

Claim 9

A process for preparing an augmenting and enhancing factor for human antibody production, comprising: obtaining mononuclear cells from human tonsils, separating lymphocytes from the mononuclear cells, suspending the obtained lymphocytes in a culture medium supplemented from fetal calf serum, adding the obtained lymphocyte suspension into a nylon wool column, eluting with the same culture medium to take off or remove nylon wool-passed lymphocytes to obtain nylon wool-adherent lymphocytes, washing off the nylon wool-adherent lymphocytes from the nylon wool, centrifuging the washed solution, suspending the obtained nylon wool-adherent lymphocytes into a culture medium supplemented with fetal calf serum, culturing the suspension in an atmosphere containing carbon dioxide and at a temperature of about 35°-38° C. for 1-7 days, centrifuging the cultured cell suspension to remove the lymphocytes, passing the obtained cultured cell supernatant through a dialysis membrane, obtaining diffused dialysate through a dialysis membrane containing the augmenting and enhancing factor which factors have a molecular weight of about 2,000-4,000, and lyophilizing the dialysate.

Claim 10

A process for preparing an augmenting and enhancing factor for human antibody production, comprising: obtaining mononuclear cells from human tonsils, separating lymphocytes from the mononuclear cells, suspending the obtained lymphocytes in a culture medium supplemented from fetal calf serum, adding the obtained lymphocyte suspension into a nylon wool column, eluting with the same culture medium to take off or remove nylon wool-passed lymphocytes to obtain nylon wool-adherent lymphocytes, washing off the nylon wool-adherent lymphocytes from the nylon wool, centrifuging the washed solution, suspending the obtained nylon wool-adherent lymphocytes into a culture medium supplemented with fetal calf serum, culturing the suspension in an atmosphere containing carbon dioxide and at a temperature of about 35°-38° C. for 1-7 days, centrifuging the cultured cell suspension to remove the lymphocytes, passing the obtained cultured cell supernatant through a dialysis membrane, obtaining diffused dialysate through a dialysis membrane containing the augmenting and enhancing factor which factors have a molecular weight of about 2,000-4,000, and lyophilizing the dialysate.